Cronos Group PE Ratio 2017-2020 | CRON

Current and historical p/e ratio for Cronos Group (CRON) from 2017 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cronos Group PE ratio as of July 06, 2020 is 64.50.
Cronos Group PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-06 6.45 7.01
2020-03-31 5.67 $0.92 6.16
2019-12-31 7.67 $1.08 7.10
2019-09-30 9.05 $0.87 10.40
2019-06-30 15.98 $0.44 36.32
2019-03-31 18.43 $0.28 65.82
2018-12-31 10.39 $-0.09 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.250B $0.026B
Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.827B 37.36
Takeda Pharmaceutical (TAK) Japan $55.678B 9.76
Astellas Pharma (ALPMY) Japan $30.701B 15.56
Eisai (ESALY) Japan $23.773B 20.61
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $15.761B 20.67
Grifols, S.A (GRFS) Spain $13.098B 16.28
Neurocrine Biosciences (NBIX) United States $11.855B 54.79
Catalent (CTLT) United States $11.390B 44.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.467B 45.02
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.978B 31.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.155B 9.85
United Therapeutics (UTHR) United States $5.239B 9.93
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.450B 485.78
Nektar Therapeutics (NKTR) United States $4.268B 0.00
Evotec AG (EVTCY) Germany $4.181B 112.67
FibroGen (FGEN) United States $3.843B 0.00
Hypermarcas (HYPMY) Brazil $3.838B 11.67
ChemoCentryx (CCXI) United States $3.578B 0.00
PTC Therapeutics (PTCT) United States $3.540B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.609B 10.72
Pacira BioSciences (PCRX) United States $2.285B 46.78
Sage Therapeutics (SAGE) United States $2.178B 0.00
Corcept Therapeutics (CORT) United States $1.916B 19.00
Xencor (XNCR) United States $1.867B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.743B 0.00
Akebia Therapeutics (AKBA) United States $1.702B 0.00
Indivior (INVVY) United States $1.679B 20.84
USANA Health Sciences (USNA) United States $1.672B 17.15
Ironwood Pharmaceuticals (IRWD) United States $1.637B 12.52
Zogenix (ZGNX) United States $1.609B 0.00
Karyopharm Therapeutics (KPTI) United States $1.431B 0.00
Esperion Therapeutics (ESPR) United States $1.404B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.401B 15.10
Heron Therapeutics (HRTX) United States $1.357B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.258B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.095B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 45.09
Tilray (TLRY) Canada $0.980B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.873B 0.00
ImmunoGen (IMGN) United States $0.853B 0.00
Endo (ENDP) Ireland $0.830B 1.29
Radius Health (RDUS) United States $0.657B 0.00
Aerie Pharmaceuticals (AERI) United States $0.648B 0.00
Trillium Therapeutics (TRIL) Canada $0.635B 0.00
Molecular Templates (MTEM) United States $0.635B 0.00
Ardelyx (ARDX) United States $0.629B 0.00
Collegium Pharmaceutical (COLL) United States $0.602B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.573B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.568B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.507B 12.25
Flexion Therapeutics (FLXN) United States $0.505B 0.00
VAXART, INC (VXRT) United States $0.478B 0.00
Innate Pharma SA (IPHYF) France $0.476B 0.00
Siga Technologies (SIGA) United States $0.475B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.458B 17.85
DURECT (DRRX) United States $0.418B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.411B 0.00
Harpoon Therapeutics (HARP) United States $0.411B 0.00
Ocular Therapeutix (OCUL) United States $0.403B 0.00
TherapeuticsMD (TXMD) United States $0.397B 0.00
Organogenesis Holdings (ORGO) United States $0.386B 0.00
MEI Pharma (MEIP) United States $0.363B 0.00
Calithera Biosciences (CALA) United States $0.360B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.324B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.299B 0.00
Concert Pharmaceuticals (CNCE) United States $0.292B 0.00
Lannett Co Inc (LCI) United States $0.287B 6.29
PROFOUND MEDICL (PROF) Canada $0.274B 0.00
OptiNose (OPTN) United States $0.254B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.250B 0.00
CASI Pharmaceuticals (CASI) United States $0.249B 0.00
Redhill Biopharma (RDHL) Israel $0.244B 0.00
Taiwan Liposome (TLC) Taiwan $0.227B 0.00
KalVista Pharmaceuticals (KALV) United States $0.225B 0.00
Jounce Therapeutics (JNCE) United States $0.222B 5.29
Rafael Holdings (RFL) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 24.05
IMV INC (IMV) Canada $0.179B 0.00
Nivalis Therapeutics (ALPN) United States $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.159B 0.00
Altimmune (ALT) United States $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.136B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
Recro Pharma (REPH) United States $0.105B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.104B 0.00
Xeris Pharmaceuticals (XERS) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.102B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Otonomy (OTIC) United States $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.098B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.088B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
Biomerica (BMRA) United States $0.077B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Heat Biologics (HTBX) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.070B 0.00
Lipocine (LPCN) United States $0.069B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.45
PolarityTE (PTE) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
Novan (NOVN) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.87
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
GTx (ONCT) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 84.64
IsoRay (ISR) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00